886 related articles for article (PubMed ID: 2822802)
1. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
3. Negative effect of a protein kinase C inhibitor (H-7) on human polymorphonuclear neutrophil locomotion.
Gaudry M; Perianin A; Marquetty C; Hakim J
Immunology; 1988 Apr; 63(4):715-9. PubMed ID: 2835313
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
Donabedian H; Gallin JI
J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
[TBL] [Abstract][Full Text] [Related]
6. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
Kurrasch R; Elfman F; Perez HD
J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor.
Gerard C; McPhail LC; Marfat A; Stimler-Gerard NP; Bass DA; McCall CE
J Clin Invest; 1986 Jan; 77(1):61-5. PubMed ID: 3003155
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
10. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
11. Dual effect of phorbol myristate acetate on chemoattractant-induced locomotion of human neutrophils.
Gaudry M; Marquetty C; Hakim J
Nouv Rev Fr Hematol (1978); 1990; 32(3):191-8. PubMed ID: 2170935
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
14. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
15. Independent regulation of human neutrophil chemotactic receptors after activation.
Bender JG; Van Epps DE; Chenoweth DE
J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
[TBL] [Abstract][Full Text] [Related]
16. Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients.
Anderson DC; Hughes BJ; Wible LJ; Perry GJ; Smith CW; Brinkley BR
J Leukoc Biol; 1984 Jul; 36(1):1-15. PubMed ID: 6376671
[TBL] [Abstract][Full Text] [Related]
17. The bacterial peptide N-formyl-Met-Leu-Phe inhibits killing of Staphylococcus epidermidis by human neutrophils in fibrin gels.
Li Y; Loike JD; Ember JA; Cleary PP; Lu E; Budhu S; Cao L; Silverstein SC
J Immunol; 2002 Jan; 168(2):816-24. PubMed ID: 11777977
[TBL] [Abstract][Full Text] [Related]
18. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
Ternowitz T; Fogh K; Kragballe K
Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
20. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
